Trends and Drivers of Pharmaceutical Expenditures from Systemic Anti-Cancer Therapy
The European journal of health economics(2022)
摘要
Expenditures on medicine for systemic anti-cancer therapy (SACT) have seen large increases in recent years. The characterization of patients with high SACT costs is crucial to identify cost-driving factors, but little is known about the distribution of expenditures at the patient-level. We priced 260,834 registrations of SACT for 12,589 patients from 2008 to 2019 by combining them with product-level billings of EUR 142.1 million. Based on this, we defined high-cost patients as the 2.5
更多查看译文
关键词
Systemic anti-cancer therapy,Medicine expenditures,High utilizers,High-cost patients,Expensive patients,Oncology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要